205 related articles for article (PubMed ID: 35460331)
1. Incidence and determinants of thrombotic and bleeding complications in patients with glioblastoma.
Kaptein FHJ; Stals MAM; Kapteijn MY; Cannegieter SC; Dirven L; van Duinen SG; van Eijk R; Huisman MV; Klaase EE; Taphoorn MJB; Versteeg HH; Buijs JT; Koekkoek JAF; Klok FA
J Thromb Haemost; 2022 Jul; 20(7):1665-1673. PubMed ID: 35460331
[TBL] [Abstract][Full Text] [Related]
2. Risk of venous thromboembolism and major bleeding in the clinical course of osteosarcoma and Ewing sarcoma.
Kaptein FHJ; Stals MAM; Evenhuis RE; Gelderblom H; Huisman MV; Karis DSA; Noten RWD; Cannegieter SC; Speetjens FM; Verschoor AJ; Versteeg HH; van de Sande MAJ; Klok FA
Thromb Res; 2023 Jan; 221():19-25. PubMed ID: 36435048
[TBL] [Abstract][Full Text] [Related]
3. Risk of venous thromboembolism and bleeding after major surgery for ovarian cancer: standard in-hospital versus extended duration of thromboprophylaxis.
Wiegers HMG; Schaafsma M; Guman NAM; Zelisse HS; Mulder FI; Middeldorp S; van Es N; Mom CH
J Thromb Haemost; 2023 Feb; 21(2):294-302. PubMed ID: 36700503
[TBL] [Abstract][Full Text] [Related]
4. Targeted DNA sequencing to identify genetic aberrations in glioblastoma that underlie venous thromboembolism; a cohort study.
Kapteijn MY; Kaptein FHJ; Stals MAM; Klaase EE; García-Ortiz I; van Eijk R; Ruano D; van Duinen SG; Cannegieter SC; Taphoorn MJB; Dirven L; Koekkoek JAF; Klok FA; Versteeg HH; Buijs JT
Thromb Res; 2023 Jan; 221():10-18. PubMed ID: 36435047
[TBL] [Abstract][Full Text] [Related]
5. Prevalence, Treatment, and Prognosis of Tumor Thrombi in Renal Cell Carcinoma.
Kaptein FHJ; van der Hulle T; Braken SJE; van Gennep EJ; Buijs JT; Burgmans MC; Cannegieter SC; du Chatinier EME; Huisman MV; van Persijn van Meerten EL; Versteeg HH; Pelger RCM; Klok FA
JACC CardioOncol; 2022 Nov; 4(4):522-531. PubMed ID: 36444235
[TBL] [Abstract][Full Text] [Related]
6. Risk factors of arterial thrombotic events after unprovoked venous thromboembolism, and after cancer associated venous thromboembolism: A prospective cohort study.
Noumegni SR; Didier R; Mansourati V; Tromeur C; Le Moigne E; Hoffmann C; Nasr B; Gentric JC; Guegan M; Poulhazan E; Lacut K; Bressollette L; Le Mao R; Couturaud F
Thromb Res; 2022 Jun; 214():93-105. PubMed ID: 35525202
[TBL] [Abstract][Full Text] [Related]
7. Predictors of Recurrent Venous Thromboembolism or Arterial Thrombotic Events during and after Anticoagulation for a First Venous Thromboembolism.
Noumegni SR; Tromeur C; Hoffmann C; Mao RL; Moigne EL; Moreuil C; Mansourati V; Nasr B; Gentric JC; Guegan M; Poulhazan E; Bressollette L; Lacut K; Didier R; Couturaud F
Semin Thromb Hemost; 2023 Oct; 49(7):688-701. PubMed ID: 36252603
[TBL] [Abstract][Full Text] [Related]
8. Arterial and Venous Thromboembolism in ALK-Rearrangement-Positive Non-small Cell Lung Cancer: A Population-Based Cohort Study.
Icht O; Leader A; Batat E; Yosef L; Shochat T; Goldstein DA; Dudnik E; Spectre G; Raanani P; Hammerman A; Zer A
Oncologist; 2023 Jun; 28(6):e391-e396. PubMed ID: 37014824
[TBL] [Abstract][Full Text] [Related]
9. Predictors of Venous Thromboembolism in Patients with Glioblastoma.
Nabi S; Kahlon P; Bozorgnia F; Arshad A; Mikkelsen T; Donthireddy V
Pathol Oncol Res; 2016 Apr; 22(2):311-6. PubMed ID: 26547860
[TBL] [Abstract][Full Text] [Related]
10. Incidence and clinical impact of bleeding events in older patients with acute venous thromboembolism.
Ferrazzini E; Méan M; Stalder O; Limacher A; Rodondi N; Aujesky D
Blood Adv; 2023 Jan; 7(2):205-213. PubMed ID: 35381071
[TBL] [Abstract][Full Text] [Related]
11. Risk and complications of venous thromboembolism in dialysis patients.
Molnar AO; Bota SE; McArthur E; Lam NN; Garg AX; Wald R; Zimmerman D; Sood MM
Nephrol Dial Transplant; 2018 May; 33(5):874-880. PubMed ID: 28992258
[TBL] [Abstract][Full Text] [Related]
12. Bevacizumab Use and the Risk of Arterial and Venous Thromboembolism in Patients with High-Grade Gliomas: A Nested Case-Control Study.
Lee I; Adimadhyam S; Nutescu EA; Zhou J; Asfaw AA; Sweiss KI; Patel PR; Calip GS
Pharmacotherapy; 2019 Sep; 39(9):921-928. PubMed ID: 31332810
[TBL] [Abstract][Full Text] [Related]
13. High incidence of venous thromboembolism recurrence in patients with sickle cell disease.
Brunson A; Keegan T; Mahajan A; White R; Wun T
Am J Hematol; 2019 Aug; 94(8):862-870. PubMed ID: 31074115
[TBL] [Abstract][Full Text] [Related]
14. Venous and arterial thromboembolism after colorectal cancer in the Netherlands: Incidence, predictors, and prognosis.
Anijs RJS; Chen Q; van der Hulle T; Versteeg HH; Klok FA; Lijfering WM; Cannegieter SC
Thromb Res; 2023 Sep; 229():90-98. PubMed ID: 37421683
[TBL] [Abstract][Full Text] [Related]
15. The cumulative venous thromboembolism incidence and risk factors in intensive care patients receiving the guideline-recommended thromboprophylaxis.
Zhang C; Zhang Z; Mi J; Wang X; Zou Y; Chen X; Nie Z; Luo X; Gan R
Medicine (Baltimore); 2019 Jun; 98(23):e15833. PubMed ID: 31169685
[TBL] [Abstract][Full Text] [Related]
16. A high Gas6 level in plasma predicts venous thromboembolism recurrence, major bleeding and mortality in the elderly: a prospective multicenter cohort study.
Schnegg-Kaufmann A; Calzavarini S; Limacher A; Mean M; Righini M; Staub D; Beer JH; Frauchiger B; Osterwalder J; Kucher N; Matter CM; Husmann M; Banyai M; Aschwanden M; Mazzolai L; Hugli O; Nagler M; Daskalakis M; Rodondi N; Aujesky D; Angelillo-Scherrer A
J Thromb Haemost; 2019 Feb; 17(2):306-318. PubMed ID: 30570809
[TBL] [Abstract][Full Text] [Related]
17. Age and long-term outcomes of patients with venous thromboembolism: From the COMMAND VTE Registry.
Takahashi K; Yamashita Y; Morimoto T; Tada T; Sakamoto H; Takase T; Hiramori S; Kim K; Oi M; Akao M; Kobayashi Y; Chen PM; Murata K; Tsuyuki Y; Nishimoto Y; Sakamoto J; Togi K; Mabuchi H; Takabayashi K; Kato T; Ono K; Kimura T;
Int J Cardiol; 2023 Jul; 383():89-95. PubMed ID: 37156304
[TBL] [Abstract][Full Text] [Related]
18. Comparison Between Non-vitamin K Antagonist Oral Anticoagulants and Low-Molecular-Weight Heparin in Asian Individuals With Cancer-Associated Venous Thromboembolism.
Chen DY; Tseng CN; Hsieh MJ; Lan WC; Chuang CK; Pang ST; Chen SW; Chen TH; Chang SH; Hsieh IC; Chu PH; Wen MS; Chen JS; Chang JW; See LC; Huang WK
JAMA Netw Open; 2021 Feb; 4(2):e2036304. PubMed ID: 33533929
[TBL] [Abstract][Full Text] [Related]
19. High incidence of venous thromboembolism and major bleeding in patients with primary CNS lymphoma.
Mahajan A; Brunson A; Keegan THM; Rosenberg A; Wun T
Leuk Lymphoma; 2020 Nov; 61(11):2605-2613. PubMed ID: 32573292
[TBL] [Abstract][Full Text] [Related]
20. Incremental Health Care Burden of Bleeding Among Patients with Venous Thromboembolism in the United States.
Amin A; Bruno A; Trocio J; Lin J; Lingohr-Smith M
J Manag Care Spec Pharm; 2015 Oct; 21(10):965-72. PubMed ID: 26402395
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
